Christopher Yea Kal Vista Pharmaceuticals, Inc. (KALV) insider trading activity
Christopher Yea is CHIEF DEVELOPMENT OFFICER of KalVista Pharmaceuticals, Inc.. Currently has a direct ownership of 91,142 shares of KALV, which is worth approximately $815,720. The most recent transaction as insider was on Aug 17, 2022, when has been sold 1,773 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).
Shares Held (Direct Ownership)
91.1K
6.38%
3M change
97.94%
12M change
Total Value Held
$815,720
Christopher Yea Transaction History
CY
Christopher Yea
CHIEF DEVELOPMENT OFFICER
Cambridge, MA